About bioProtonics
bioProtonics is a private company based in Santa Barbara, California. It has reported $9,631,892 raised in ten offerings on Form D since March 2019. Its chief executive is A. Tripathi.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 24, 2025 | Jul 25, 2025amended Apr 9, 2026 | $1,015,000of $2.5M target | 6 | $169K | Debt, Options, Securities on exercise, Convertible Notes & WarrantsRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 31, 2024 | Dec 31, 2024 | $2,701,248fully sold | 18 | $150K | EquityRule 506(b) | Form D ↗ |
| Apr 20, 2023 | Apr 21, 2023 | $74,415fully sold | 1 | $74,415 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 18, 2023 | Jan 18, 2023 | $108,900fully sold | 3 | $36,300 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 14, 2022 | Sep 15, 2022amended Apr 10, 2024 | $1,893,126of $2.5M target | 13 | $145K | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗3 earlier filings |
| Aug 4, 2021 | Aug 10, 2021 | $1,048,785fully sold | 5 | $209K | EquityRule 506(b) | Form D ↗ |
| Mar 24, 2020 | Mar 19, 2021 | $576,952of $1.0M target | 4 | $144K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 24, 2020 | Mar 25, 2020amended Jul 1, 2021 | $836,952of $1.0M target | 6 | $139K | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
| Mar 24, 2020 | Mar 25, 2020 | $594,527fully sold | 5 | $118K | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 4, 2019 | Mar 7, 2019amended Jan 9, 2020 | $781,987of $1.5M target | 4 | $195K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, ten offerings | $9,631,892 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on bioProtonics's Form D filed Apr 9, 2026.
Earlier filings also listed Forrest Fleming (chief executive officer and director, last listed Dec 2024), Charles Winckler (executive officer, last listed Aug 2021), W. James (director, last listed Jul 2021), Scott Cannizzaro (ceo and director, last listed Mar 2020), Daniel Doioron (executive officer and director, last listed Mar 2020) and Chris Corpuz (executive officer, last listed Mar 2020).
Sources
- SECbioProtonics, Inc. Form D, filed Jul 25, 2025
- SECbioProtonics, Inc. Form D/A, filed Sep 20, 2023
- SECbioProtonics, Inc. Form D/A, filed Sep 12, 2023
- SECbioProtonics, Inc. Form D, filed Sep 15, 2022
- SECbioProtonics, Inc. Form D/A, filed Mar 19, 2021
- SECbioProtonics, Inc. Form D, filed Mar 25, 2020
- SECbioProtonics, Inc. Form D/A, filed Jul 25, 2019
- SECbioProtonics, Inc. Form D, filed Mar 7, 2019
- SECbioProtonics, Inc. filing history
- CompanybioProtonics team